Sittner & Nelson’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.97M | Hold |
25,145
| – | – | 0.79% | 27 |
|
2025
Q1 | $1.82M | Sell |
25,145
-200
| -0.8% | -$14.5K | 0.78% | 25 |
|
2024
Q4 | $1.88M | Buy |
25,345
+600
| +2% | +$44.4K | 0.81% | 25 |
|
2024
Q3 | $1.63M | Buy |
24,745
+730
| +3% | +$48.2K | 0.73% | 27 |
|
2024
Q2 | $2.22M | Sell |
24,015
-600
| -2% | -$55.4K | 1.09% | 20 |
|
2024
Q1 | $2.35M | Buy |
24,615
+340
| +1% | +$32.5K | 1.19% | 20 |
|
2023
Q4 | $1.85M | Buy |
24,275
+550
| +2% | +$41.9K | 0.99% | 23 |
|
2023
Q3 | $1.64M | Sell |
23,725
-240
| -1% | -$16.6K | 0.95% | 25 |
|
2023
Q2 | $2.26M | Hold |
23,965
| – | – | 1.24% | 18 |
|
2023
Q1 | $1.98M | Sell |
23,965
-300
| -1% | -$24.8K | 1.14% | 16 |
|
2022
Q4 | $1.81M | Sell |
24,265
-400
| -2% | -$29.8K | 1.11% | 17 |
|
2022
Q3 | $2.04M | Hold |
24,665
| – | – | 1.37% | 15 |
|
2022
Q2 | $2.35M | Buy |
24,665
+400
| +2% | +$38K | 1.53% | 11 |
|
2022
Q1 | $2.86M | Buy |
24,265
+1,073
| +5% | +$126K | 1.65% | 10 |
|
2021
Q4 | $3.01M | Buy |
23,192
+127
| +0.6% | +$16.5K | 1.75% | 10 |
|
2021
Q3 | $2.61M | Hold |
23,065
| – | – | 1.69% | 12 |
|
2021
Q2 | $2.39M | Hold |
23,065
| – | – | 1.68% | 14 |
|
2021
Q1 | $1.93M | Hold |
23,065
| – | – | 1.44% | 17 |
|
2020
Q4 | $2.1M | Buy |
+23,065
| New | +$2.1M | 1.89% | 12 |
|